bearish

SciClone Pharmaceuticals IPO Valuation: Not Pleasing

329 Views22 Feb 2021 15:47
SciClone has set the terms for its IPO, where it plans to issue approx. 116m shares at an indicative IPO price range of HK$17.2-18.8 per share to raise about HK$1.9-2.0bn (approx. US$240-263m).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 5-minute read)
Discussions
(Paid Plans Only)
chart-bar
x